• David Whitaker, Guttorm Brattebø, Stefan Trenkler, Indulis Vanags, Flavia Petrini, Zuhal Aykac, Dan Longrois, Stephan Alexander Loer, Tomasz Gaszynski, Jurate Sipylaite, Elena Copaciu, Vladimir Cerny, Jonas Akeson, Jannicke Mellin-Olsen, Carmel Abela, Adela Stecher, Sibylle Kozek-Langenecker, Indrek Rätsep, and European Section and Board of Anaesthesiology of the UEMS.
• From the Department of Anaesthesia, Manchester Royal Infirmary, Manchester, UK (DW), Department of Anaesthesia and Intensive Care, Haukeland University Hospital, Bergen, Norway (GB), Department of Anaesthesiology and Intensive Medicine, P.J. Safarik University, Kosice, Slovakia (ST), Krompachy Agel Hospital, Krompachy (ST), Falck Zachranna a.s., Kosice, Slovakia (ST), Department of Anaesthesiology and Reanimatology, Pauls Stradins Clinical University Hospital, Riga, Latvia (IV), Department of Perioperative Medicine, Pain Therapy, RRS and ICU, Chieti University Hospital, Chieti, Italy (FP), Department of Anaesthesiology and Reanimation, Marmara University, Istanbul, Turkey (ZA), Département d'anesthésie-réanimation, Hôpital Bichat-Claude-Bernard, Paris, France (DL), Department of Anesthesiology, VU University Medical Center, Amsterdam, The Netherlands (SAL), Department of Anaesthesiology and Intensive Therapy, Medical University of Lodz, Poland (TG), Clinic of Anaesthesiology and Intensive Care, Vilnius University, Vilnius, Lithuania (JS), Department of Intensive Care, University Hospital, Carol Davila University of Medicine, Bucharest, Romania (EC), Department of Anaesthesiology, Perioperative Medicine and Intensive Care, J.E. Purkinje University, Masaryk Hospital, Usti nad Labem (VC), Department of Research and Development, Faculty of Medicine Hradec Kralove, Hradec Kralove, Czech Republic (VC), Department of Anaesthesia, Pain Management and Perioperative Medicine, Dalhousie University, Halifax, Canada (VC), Department of Anaesthesiology and Intensive Care Medicine, Lund University, Skåne University Hospital, Malmö, Sweden (JA), Department of Anaesthesiology and Intensive Care Medicine, Baerum Hospital, Oslo, Norway (JM-O), Department of Anaesthesia, Intensive Care and Pain Medicine, Mater Dei Hospital, Msida, Malta (CA), Clinical Department of Anaesthesiology and Intensive Therapy, University Clinical Center Ljubljana, Slovenia (AS), Sigmund Freud Private University Vienna and Department of Anaesthesia and Intensive Care, Evangelical Hospital Vienna, Vienna, Austria (SK-L), Department of Anaesthesiology and Intensive Care, North Estonia Medical Centre, Tallinn, Estonia (IR).
• Eur J Anaesthesiol. 2017 Jan 1; 34 (1): 4-7.

AbstractThese European Board of Anaesthesiology (EBA) recommendations for safe medication practice replace the first edition of the EBA recommendations published in 2011. They were updated because evidence from critical incident reporting systems continues to show that medication errors remain a major safety issue in anaesthesia, intensive care, emergency medicine and pain medicine, and there is an ongoing need for relevant up-to-date clinical guidance for practising anaesthesiologists. The recommendations are based on evidence wherever possible, with a focus on patient safety, and are primarily aimed at anaesthesiologists practising in Europe, although many will be applicable elsewhere. They emphasise the importance of correct labelling practice and the value of incident reporting so that lessons can be learned, risks reduced and a safety culture developed.

22 keywords...

hide…